| 臺大學術典藏 |
2020-09-07T06:32:41Z |
Prevention of colitis and colitis-associated colorectal cancer by a novel polypharmacological histone deacetylase inhibitor
|
TZU-TANG WEI; Lin Y.-T.; Tseng R.-Y.; Shun C.-T.; Lin Y.-C.; Wu M.-S.; Fang J.-M.; Chen C.-C. |
| 臺大學術典藏 |
2020-09-07T06:32:40Z |
Corrigendum to “Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer” (EBioMedicine Aug 2016; 10: 124–36) (S2352396416303243) (10.1016/j.ebiom.2016.07.019))
|
TZU-TANG WEI |
| 臺大學術典藏 |
2020-09-07T06:32:40Z |
Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes
|
Wu J.C.; Ong S.-G.; Lee W.H.; Chen W.-Y.; Shao N.-Y.; Xiao D.; Qin X.; Baker N.; Bae H.R.; TZU-TANG WEI; Wang Y.; Shukla P.; Wu H.; Kodo K. |
| 臺大學術典藏 |
2020-09-07T06:32:40Z |
Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo
|
Kooreman N.G.; Kim Y.; de Almeida P.E.; Termglinchan V.; Diecke S.; Shao N.-Y.; TZU-TANG WEI; Yi H.; Dey D.; Nelakanti R.; Brouwer T.P.; Paik D.T.; Sagiv-Barfi I.; Han A.; Quax P.H.A.; Hamming J.F.; Levy R.; Davis M.M.; Wu J.C. |
| 臺大學術典藏 |
2020-09-07T06:32:39Z |
Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress (Oncotarget (2019) 10 (3577-3578) DOI: 10.18632/oncotarget.1628)
|
Lin Y.-C.;Wu M.-H.;Tzu-Tang Wei;Lin Y.-C.;Huang W.-C.;Huang L.-Y.;Lin Y.-T.;Chen C.-C.; Lin Y.-C.; Wu M.-H.; TZU-TANG WEI; Lin Y.-C.; Huang W.-C.; Huang L.-Y.; Lin Y.-T.; Chen C.-C. |
| 臺大學術典藏 |
2020-09-07T06:32:38Z |
Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer
|
Tzu-Tang Wei;Lin Y.-T.;Tang S.-P.;Luo C.-K.;Tsai C.-T.;Shun C.-T.;Chen C.-C.; TZU-TANG WEI; Lin Y.-T.; Tang S.-P.; Luo C.-K.; Tsai C.-T.; Shun C.-T.; Chen C.-C. |
| 臺大學術典藏 |
2017 |
Corrigendum to “Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells” [Neoplasia (United States) 14 (2012) 463–475](S1476558612801023)(10.1596/neo.12300)
|
Chen C.-C.; Lin Y.-C.; Wu M.-H.; TZU-TANG WEI; Chuang S.-H.; Chen K.-F.; Cheng A.-L. |
| 義守大學 |
2015-07 |
MiRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin
|
Wen-Shu Chen;Chia-Jui Yen;Yun-Ju Chen;Jhen-Yu Chen;Li-Yun Wang;Shu-Jun Chiu;Wen-Ling Shih;Chien-Yi Ho;Tzu-Tang Wei;Hsiao-Lin Pan;Pei-Hsuan Chien;Mien-Chie Hung;Ching-Chow Chen;Wei-Chien Huang |
| 亞洲大學 |
2015-07 |
MiRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.
|
Chen), Wen-Shu Chen(Wen-Shu;Yen), Chia-Jui Yen(Chia-Jui;Chen), Yun-Ju Chen(Yun-Ju;Chen), Jhen-Yu Chen(Jhen-Yu;Wang), Li-Yun Wang(Li-Yun;Chiu), Shu-Jun Chiu(Shu-Jun;Shi, Wen-Ling;Ho, Chien-Yi;(Tzu-Tang Wei,);Chien), Pei-Hsuan Ch(Pei-Hsuan;洪明奇;Chen), Ching-Chow C(Ching-Chow;Huang)*, 黃偉謙(Wei-Chien |
| 亞洲大學 |
2015 |
MiRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.
|
Wen-Shu Chen(Wen-Shu Chen); Chia-Jui Yen(Chia-Jui Yen); Yun-Ju Chen(Yun-Ju Chen); Jhen-Yu Chen(Jhen-Yu Chen); Li-Yun Wang(Li-Yun Wang); Shu-Jun Chiu(Shu-Jun Chiu); Wen-Ling Shi; Chien-Yi Ho; , (Tzu-Tang Wei,); Pei-Hsuan Ch(Pei-Hsuan Chien); 洪明奇; Ching-Chow C(Ching-Chow Chen); 黃偉謙(Wei-Chien Huang)* |
| 亞洲大學 |
2015 |
MiRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.
|
Chen, Wen-Shu;Chen, Wen-Shu;Yen, Chia-Jui;Yen, Chia-Jui;Chen, Yun-Ju;Chen, Yun-Ju;Chen, Jhen-Yu;Chen, Jhen-Yu;Wang, Li-Yun;Wang, Li-Yun;Chiu, Shu-Jun;Chiu, Shu-Jun;Wen-Ling Shi Chien-Yi Ho , ;Tzu-Tang Wei, ;Ch, Pei-Hsuan;Chien, Pei-Hsuan;Chen, Ching-Chow;黃偉謙;Huang, Wei-Chien |
| 臺大學術典藏 |
2015 |
miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin
|
Chen Y.-J.; Chen J.-Y.; Wang L.-Y.; Chiu S.-J.; Shih W.-L.; Ho C.-Y.; TZU-TANG WEI; Pan H.-L.; Chien P.-H.; Hung M.-C.; Chen C.-C.; Huang W.-C.; Chen W.-S.;Yen C.-J.;Chen Y.-J.;Chen J.-Y.;Wang L.-Y.;Chiu S.-J.;Shih W.-L.;Ho C.-Y.;Tzu-Tang Wei;Pan H.-L.;Chien P.-H.;Hung M.-C.;Chen C.-C.;Huang W.-C.; Chen W.-S.; Yen C.-J. |
| 臺大學術典藏 |
2015 |
Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer
|
TZU-TANG WEI; Lin Y.-C.; Lin P.-H.; Shih J.-Y.; Chou C.-W.; Huang W.-J.; Yang Y.-C.; Hsiao P.-W.; Chen C.-C. |
| 臺大學術典藏 |
2013 |
Design and synthesis of dual-action inhibitors targeting histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase for cancer treatment
|
Chen J.-B.; Chern T.-R.; TZU-TANG WEI; Chen C.-C.; Lin J.-H.; Fang J.-M. |
| 臺大學術典藏 |
2011 |
Role of pirenoxine in the effects of catalin on in vitro ultravioletinduced lens protein turbidity and selenite-induced cataractogenesis in vivo
|
Wu T.-H.; Wu S.-H.; Chen H.-Y.; Chiu S.-J.; Hu C.-C. ;Liao J.-H. ;Hsu K.-Y. ;Lin I.-L. ;Tsai M.-H. ;Wu W.-H. ;Tzu-Tang Wei ;Huang Y.-S. ;Chiu S.-J. ;Chen H.-Y. ;Wu S.-H. ;Wu T.-H.; Hu C.-C.; Liao J.-H.; Hsu K.-Y.; Lin I.-L.; Tsai M.-H.; Wu W.-H.; TZU-TANG WEI; Huang Y.-S. |
